Skip to main content
SpringerLink
Log in

Molecular Pharmacology, a Basis for Drug Design

  • Chapter
Fortschritte der Arzneimittelforschung / Progress in Drug Research / Progrès des recherches pharmaceutiques

  • 85 Accesses

Abstract

Reading the title of this contribution many pharmacologists, especially medicinal chemists, may assume that this is a presentation in the field of science fiction. They know too well that the design of drugs has been tried for many years but that many, if not most, drugs used in these days are not the products but more the by-products of efforts in drug design.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. H. H. Fox, Trans. N.Y. Acad. Sci. [Ser. II] 13, (1953), 240.

    Google Scholar 

  2. H. K. von Rechenberg, Phenylbutazone: Butazolidin, translated from the 2nd Ger. Edn (E. Arnold, London 1962 ).

    Google Scholar 

  3. H. G. Mandel and C. Davison, in: Drill’s Pharmacology in Medicine, 3rd Edn, p. 306 (Ed. J. R. Dipalma, Mcgraw-Hill Book Comp., New York 1965 ).

    Google Scholar 

  4. A. Loubatieres, Ann. N.Y. Acad. Sci. 71(1957), 4.

    Google Scholar 

  5. H. Frankeand J. Fuchs, Dt. med. Wschr. 80(1955), 1449.

    Google Scholar 

  6. G. F. Mcmahon, in: Molecular Modification in Drug Design(Ed., R. F. Gould), Adv. Chem. Ser. 45, 102 ( Am. chem. Soc., Washington 1964 ).

    Google Scholar 

  7. H. Southworth, Proc. Soc. exp. Biol. Med. 36(1937), 58.

    Google Scholar 

  8. J. M. Sprague, Ann. N.Y. Acad. Sci. 71(1958), 328.

    Google Scholar 

  9. H. A. Krebs, Biochem. J. 43(1948), 525.

    Google Scholar 

  10. C. K. Friedberg, M. Halperand R. Taymor, J. clin. Invest. 31(1952), 1074.

    Google Scholar 

  11. D. Bar, Act. pharm. 15, 1 (Eds., E. Hazard et J. Cheymol, Masson et Cie., Paris 1963 ).

    Google Scholar 

  12. B. B. Brodie, The Pharmacologist 6(1964), 12.

    Google Scholar 

  13. B. B. Brodie, J. Pharm. Pharmac. 8(1956), 1.

    Google Scholar 

  14. R. T. Williams, Detoxication Mechanisms, 2nd Edn ( Wiley, New York 1959 ).

    Google Scholar 

  15. A. Burger, New Engl. J. Med. 270(1964), 1099.

    Google Scholar 

  16. E. J. Arièns, Molecular Pharmacology, Vol. I ( Acad. Press, New York 1964 ).

    Google Scholar 

  17. P. Ehrlich, Proc. 17th Int. Congr. Med. (1913).

    Google Scholar 

  18. J. N. Langiey, J. Physiol. 33(1905), 374.

    Google Scholar 

  19. P. A. E. Desnuelle, Molecular Basis of Enzyme Action and Inhibition, Proc. 5th Int. Congr. Biochem., Moscow 1961 ( Pergamon Press, Oxford 1963 ).

    Google Scholar 

  20. E. M. Kosower, Molecular Biochemistry, p. 274 ( Mcgraw-Hill Book Comp., New York 1962 ).

    Google Scholar 

  21. J. L. Mongarand AYS. de Reuck, Ciba Foundation Symposium on Enzymes and Drug Action(J. and A. Churchill Ltd., London 1962 ).

    Google Scholar 

  22. J. A. Cohenand RA. Oosterbaan, Handb. exp. Pharmak. 15, 300 ( Springer Verlag, Basel 1963 ).

    Google Scholar 

  23. H. Gutfreund, An Introduction to the Study of Enzymes (Blackwell Sci. Pubi., Oxford 1965 ).

    Google Scholar 

  24. J. M. van Rossum : Molecular Pharmacology, vol. II, p. 199 (Ed., E. J. Arièns, Acad. Press, New York 1964 ).

    Google Scholar 

  25. M. Tishler, in: Molecular Modification in Drug Design(Ed., R. F. Gould), Adv. Chem. Ser. 45, 1 ( Am. Chem. Soc., Washington 1964 ).

    Google Scholar 

  26. H. G. Mandeland C. Davison, in: Drill’s Pharmacology in Medicine, 3rd Edn, p. 306 (Ed., J. R. Dipalma, Mcgraw-Hill Book Comp., New York 1965 ).

    Google Scholar 

  27. W. J. Hayes, jr. in: The Insecticide Dichlorodiphenyltrichloroethane and Its Significance, vol. 2 (Ed., P. Müller, Birkhäuser, Basel 1959 ).

    Google Scholar 

  28. G. Domagk, Dt. med. Wschr. 61(1935), 250.

    Google Scholar 

  29. F. W. Schofield, J. Am. vet. med. Ass. 64(1924), 553.

    Google Scholar 

  30. J. B. Bingham, O. O. Meyerand FJ. Pohle, Am. J. med. Sci. 202(1941), 563.

    Google Scholar 

  31. K. P. Link, Harvey Lect. 39(1943–1944), 162–216.

    Google Scholar 

  32. G. I. C. Ingram, Pharmac. Rev. 13(1961), 279.

    Google Scholar 

  33. I. C. Geddes, Br. J. Anaesth. 26(1954), 208.

    Google Scholar 

  34. S. Wiedlingand C. Tegner, in: Progress in Medicinal Chemistry, Vol. 3, p. 332 (Eds., G. P. Ellisand G. B. West, Butterworths, London 1963 ).

    Google Scholar 

  35. A. Burger, Medicinal Chemistry, 2nd Edn, p. 441 ( Intersci., New York 1960 ).

    Google Scholar 

  36. E. J. Arièns, A. M. Simonis, and JM. van Rossum: Molecular Pharmacology, vol. I, p. 351, 371 (Ed., E. J. Arièns, Acad. Press, New York 1964 ).

    Google Scholar 

  37. M. E. Florey, The Clinical Application of Antibiotics: Penicillin (Oxford University Press, Fair Lawn, N.J. 1952 ).

    Google Scholar 

  38. Th. Wagner-Jauregg, Therapeutische Chemie, p. 160 ( Hans Huber, Bern 1949 ).

    Google Scholar 

  39. R. C. Elderfield, Chem. Engng News 24 (1946), 2598.

    Google Scholar 

  40. E. H. Reerink, in: Het Nieuwe Geneesmiddel, Boerhaave cursus University of Leiden (1964).

    Google Scholar 

  41. J. R. Gillette, in: Progress in Drug Research, vol. 6, p. 13–73 (Ed., E. Jucker, Birkhäuser, Basel 1963 ).

    Google Scholar 

  42. M. Neuenschwander, Ophthalmologia 120 (1950), 104.

    Google Scholar 

  43. P. E. Thompson, B. J. Olszewski, E. F. Elslager, and D. F. Worth, Am. J. trop. Med. Hyg. 12 (1963), 481.

    Google Scholar 

  44. J. L. Webb, Enzyme and Metabolic Inhibitors, vol. I ( Acad. Press, New York 1963 ).

    Google Scholar 

  45. J. L. Webb,Enzyme and Metabolic Inhibitors, vol. II ( Acad. Press, New York 1965 ).

    Google Scholar 

  46. J. L. Webb,Enzyme and Metabolic Inhibitors, vol. III (Acad. Press, New York 1965 ).

    Google Scholar 

  47. G. E. W. Wolstenholmeand CM. O’Connor, Ciba Foundation Symposium on Chemistry and Biology of Purines(J. and A. Churchill Ltd., London 1957 ).

    Google Scholar 

  48. G. E. W. Wolstenholmeand CM. O’Connor, Ciba Foundation Symposium on Amino Acids and Peptides with Antimetabolic Activity(J. and A. Churchill Ltd., London 1958 ).

    Google Scholar 

  49. G. J. Martin, Biological Antagonism(Blakiston, Philadelphia, Pa. 1951 ).

    Google Scholar 

  50. C. P. Rhoads, Antimetabolites and Cancer, Am. Ass. Adv. Sci. ( Baily Bros, and Swinfen, London 1955 ).

    Google Scholar 

  51. D. W. Woolley, A Study of Antimetabolites( Wiley, New York 1952 ).

    Google Scholar 

  52. T. S. Workand E. Work, The Basis of Chemotherapy( Oliver and Boyd, London 1948 ).

    Google Scholar 

  53. H. G. Mautner, Yale J. Biol. Med. 32(1960), 323.

    Google Scholar 

  54. B. B. Brodieand RP. Maickel, Proceedings 1st International Pharmacological Meeting, Stockholm 1961, vol. 6, p. 299 ( Macmillan, New York 1962 ).

    Google Scholar 

  55. R. T. Williamsand DY. Parke, Am. Rev. Pharmac. 4(1964), 85.

    Google Scholar 

  56. M. Jacobsonand M. Beroza, Scient. Am. 211(1964), 20.

    Google Scholar 

  57. A. H. Conneyand JJ. Burns, Adv. Pharmac. 1, 31 ( Acad. Press, New York 1962 ).

    Google Scholar 

  58. K. A. Lees, J. Pharm. Pharmac. 15(1963), 434.

    Google Scholar 

  59. L. E. Hollister, New Engl. J. Med. 266(1962), 281.

    Google Scholar 

  60. L. E. Hollister, S. L. Kanterand DJ. Clyde, Clin. Pharmac. Ther. 4(1963), 612.

    Google Scholar 

  61. E. J. Ariens, 2nd Int. Bronchitis SymposiumGroningen, Holland, p. 209 ( Van Gorcum, Assen 1964 ).

    Google Scholar 

  62. G. Levyand LE. Hollister, J. pharm. Sci. 54(1965), 1121.

    Google Scholar 

  63. G. Levyand T. Matsuzawa, J. pharm. Sci. 54(1965), 1003.

    Google Scholar 

  64. J. A. L. Gorringeand EM. Sproston: Absorption and Distribution of Drugs, p. 184 (Eds., T. B. Binns, E. and S. Livingstone, Edinburgh 1964 ).

    Google Scholar 

  65. P. Finholt, Pharm. Ztg 109(1964), 616.

    Google Scholar 

  66. E. J. Ariens, in: Advances in Drug Research, vol. III (Eds., N. J. Harperand AB. Simmonds, Acad. Press, London 1966 ).

    Google Scholar 

  67. B. Belleau, J. Medicinal Chem. 7(1964), 776.

    Google Scholar 

  68. B. Belleau: Advances in Drug Research, vol. II, p. 89 (Eds., NJ. Harperand AB. Simmonds, Acad. Press, New York 1965 ).

    Google Scholar 

  69. J. del Castilloand E. Engbaek, J. Physiol. 124(1954), 370.

    Google Scholar 

  70. J. M. van Rossum, E. J. Ariensand GH. Linssen, Biochem. Pharmac. 1 (1958), 193.

    Google Scholar 

  71. H. Arnold, Pharm. Ztg 109(1964), 350.

    Google Scholar 

  72. N. J. Harper, J. mednl pharm. Chem. 1(1959), 467.

    Google Scholar 

  73. T. B. Binns, Absorption and Distribution of Drugs( Livingstone Ltd., Edinburgh 1964 ).

    Google Scholar 

  74. B. B. Brodieand CAM. Hogben, J. Pharm. Pharmac. 9(1957), 345.

    Google Scholar 

  75. H. R. Ing, in: Fortschritte der Arzneimittelforschung, vol. 7, p. 306 (Ed., E. Jucker, Birkhäuser, Basel 1964 ).

    Google Scholar 

  76. C. G. Raisonand OD. Standen, Br. J. Pharmac. 10(1955), 191.

    Google Scholar 

  77. A. Burger, Medicinal Chemistry, 2nd Edn (Intersci. Publ., New York 1960 ).

    Google Scholar 

  78. R. B. Barlow, Introduction to Chemical Pharmacology, 2nd Edn ( Wiley and Sons, New York 1964 ).

    Google Scholar 

  79. J. B. van der Schoot, E. J. Ariens, J. M. van Rossum, and J. A. Th. M. Hurkmans, Arzneimittel-Forsch. 12(1962), 902.

    Google Scholar 

  80. I. Takayanagi, Arzneimittel-Forsch. 14(1964), 694.

    Google Scholar 

  81. B. B. Brodieand J. Axelrod, J. Pharmac. 97(1949), 58.

    Google Scholar 

  82. M. Kiese, Ann. N.Y. Acad. Sci. 123(1965), 141.

    Google Scholar 

  83. H. Uehleke, in: Fortschritte der Arzneimittelforschung, vol. 8, p. 197 (Ed., E. Jucker, Birkhäuser, Basel 1965 ).

    Google Scholar 

  84. P. Emmelot: Molecular Pharmacology, vol. II, p. 53 (Ed.,E. J. Ariens, Acad. Press, New York 1964 ).

    Google Scholar 

  85. H. Kurz, Pharm. Ztg 109(1964), 1.

    Google Scholar 

  86. Y. B. Schatz, in: Medicinal Chemistry, 2nd Edn, p. 72 (Ed., A. Burger, Intersci. Publ., New York 1960 ).

    Google Scholar 

  87. H. L. Friedman, Symposium on Chemical-Biological Correlation, Natn. Acad. Sci., Natn. Research Council, publ. No. 206, p. 295 (Washington D.C. 1951 ).

    Google Scholar 

  88. G. H. Hitchingsand JJ. Burchall, Adv. Enzymol. 27(1965), 417.

    Google Scholar 

  89. J. H. Burnand MJ. Rand, J. Physiol. 144(1958), 314.

    Google Scholar 

  90. J. H. Burnand MJ. Rand, Br. J. Pharmac. 15 (1960), 47.

    Google Scholar 

  91. R. P. Ahlquist, Am. J. Physiol. 153(1948), 586.

    Google Scholar 

  92. R. P. Ahlquist, in: Pharmacology in Medicine, 2nd Edn, chapter 27 (Ed., Y. Drill, Mcgraw Hill, New York 1958 ).

    Google Scholar 

  93. J. M. van Rossum, 14e Jaarboek van Kankeronderzoek en Kankerbestrijding in Nederland, p. 199 (1964).

    Google Scholar 

  94. J. M. van Rossum, in: Proceedings 5th International Congress of Neuro-Psychopharmacology, Washington 1966, vol. 4 ( Elseviers Publ., Amsterdam 1967 ).

    Google Scholar 

  95. E. J. Ariens, in: Proceedings Conference on New Adrenergic Blocking Drugs(N.Y. Acad. Sci., New York, February 1966), in press.

    Google Scholar 

  96. C. Chagas, E. Penna-Franca, A. Hasson, C. Crocker, K. Nishieand EJ. Garcia, Archs Biochem. Biophys. 75(1958), 251.

    Google Scholar 

  97. S. Ehrenpreis, Science 136(1962), 175.

    Google Scholar 

  98. G. Milhaud, in: Curare and Curare-Like Agents, No. 12, p. 10 (Ciba Foundation Study Group, 1962 ).

    Google Scholar 

  99. D. Nachmansohn, Science 136(1962), 177.

    Google Scholar 

  100. L. J. Reed, Science 138(1962), 991.

    Google Scholar 

  101. P. B. Weisz, Nature 195(1962), 772.

    Google Scholar 

  102. D. E. Greenand S. Fleischer: Horizons in Biochemistry, p. 415 (Eds., M. Kasha and B. Pullman, Acad. Press, New York 1962 ).

    Google Scholar 

  103. H. A. Harper, Review of Physiological Chemistry, p. 124 ( Lange Medical Publications, Los Altos, California, 1963 ).

    Google Scholar 

  104. H. Netter, Theoretische Biochemie, p. 497 ( Springer Verlag, Berlin 1959 ).

    Google Scholar 

  105. W. D. M. Paton, Proc. R. Soc. B 154(1961), 21.

    Google Scholar 

  106. W. D. M. Paton, in: Curare and Curare-Like Agents, No. 12, p. 34 (Ciba Foundation Study Group, 1962 ).

    Google Scholar 

  107. E. J. Ariens, J. M. van Rossum, and AM. Simonis, Pharmac. Rev. 9(1957), 218.

    Google Scholar 

  108. JH. Gaddum, Trans. Faraday Soc. 39(1943), 323.

    Google Scholar 

  109. JH. Gaddum, Pharmac. Rev. 9(1957), 211.

    Google Scholar 

  110. G. L. Eichhorn, Fed. Proc. 20(1961), 40.

    Google Scholar 

  111. D. E. Koshlandin, Proceedings 1st International Pharmacological Meeting, Stockholm 1961, vol. 7, p. 161 ( Pergamon Press, Oxford 1963 ).

    Google Scholar 

  112. D. E. Koshland, Proc. natn. Acad. Sci. 44(1958), 98.

    Google Scholar 

  113. J. L. Mongarand AVS. de Reuck, Ciba Foundation Symposium on Enzymes and Drug Action(J. and A. Churchill Ltd., London 1962 ).

    Google Scholar 

  114. E. A. Zellerand JR. Fouts, A. Rev. Pharmac. 3(1963), 9.

    Google Scholar 

  115. D. R. H. Gourley, in: Progress in Drug Research, vol. 7, p. 12 (Ed., E. Jucker, Birkhäuser Verlag, Basel 1964 ).

    Google Scholar 

  116. J. M. Thorp, in: Absorption and Distribution of Drugs, p. 64 ( Ed., T. B. Binns, E. and S. Livingstone Ltd., Edinburgh 1964 ).

    Google Scholar 

  117. E. Krüger-Thiemer, W. Diller, L. Dettli, P. Büngerand J. Seydel, Antibiótico, et Chemotherapia, Fortschritte, vol. 12, p. 171 ( Karger, Basel 1964 ).

    Google Scholar 

  118. C. M. Kunin, J. Lab. clin. Med. 65(1965), 406.

    Google Scholar 

  119. B. B. Newbouldand R. Kilpatric, Lancet 1(1960), 887.

    Google Scholar 

  120. H. Veldstra, Pharmac. Rev. 8(1956), 339.

    Google Scholar 

  121. L. S. Schanker, in: Advances in Drug Research, p. 71 ( Eds., NJ. Harperand AB. Simmonds, Acad. Press, London 1964 ).

    Google Scholar 

  122. D. R. H. Gourley, in: Progress in Drug Research, vol. 7, p. 12 (Ed., E. Jucker, Birkhäuser Verlag, Basel 1964 ).

    Google Scholar 

  123. A. Clark, Handbuch der experimentellen Pharmakologie, vol. 4 ( Springer Verlag, Berlin 1937 ).

    Google Scholar 

  124. R. P. Ahlquist, Am. J. Physiol. 153(1948), 586.

    Google Scholar 

  125. E. J. Ariens, Archs int. Pharmacodyn. Ther. 99(1954), 32.

    Google Scholar 

  126. E. J. Ariens, J. M. van Rossum, and AM. Simonis, Pharmac. Rev. 9(1957), 218.

    Google Scholar 

  127. A. Kappas, W. Soybel, P. Glickman, and D. Fukushima, A.M.A. Archs internal Med. 105(1960), 701.

    Google Scholar 

  128. E. J. Ariens, and AM. Simonis, J. Pharm. Pharmac. 16(1964), 137.

    Google Scholar 

  129. D. Neubert, Dt. med. Wschr. 83(1958), 2159.

    Google Scholar 

  130. P. A. Shore, B. B. Brodie, and CAM. Hogben, , J. Pharmac. exp. Ther. 119(1957), 361.

    Google Scholar 

  131. L. S. Shanker, PA. Shore, , B. B. Brodie, and CAM. Hogben, , J. Pharmac. exp. Ther. 120(1957), 528.

    Google Scholar 

  132. S. Mayer, R. P. Maickel, and B. B. Brodie, J. Pharmac. exp. Ther. 127(1959), 205.

    Google Scholar 

  133. B. B. Brodie, H. Kurz, and L. S. Schanker, J. Pharmac. exp. Ther. 130(1960), 20.

    Google Scholar 

  134. R. J. Mcisaacand GB. Koelle, J. Pharmac. exp. Ther. 126(1959), 9.

    Google Scholar 

  135. J. Cheymoland F. Bourillet, Actual, pharmac. 13(1961), 63.

    Google Scholar 

  136. R. Höber, Physical Chemistry of Cells and Tissues( Blakiston, Philadelphia 1945 ).

    Google Scholar 

  137. K. H. Beyer, V. D. Wiebelhaus, E. K. Tillson, H. F. Russo, , and K. M. Wilhoyte, Proc. Soc. exp. Biol. Med. 74(1950), 772.

    Google Scholar 

  138. L. Peters, Pharmac. Rev. 12(1960), 1.

    Google Scholar 

  139. K. H. Beyer, , H. F. Russo, , S. R. Gass, K. M. Wilhoyte, and A. A. Pitt, Am. J. Physiol. 160(1950), 311.

    Google Scholar 

  140. A. Farah, M. Frazer, and E. Porter, J. Pharmac. exp. Ther. 126(1959), 202.

    Google Scholar 

  141. G. A. J. Van Os, E. J. Ariens, and AM. Simonis: Molecular Pharmacology, vol. I, p. 7 (Ed., E. J. Ariens, Acad. Press, New York 1964 ).

    Google Scholar 

  142. R. M. Levineand BB. Clark, J. Pharmac. exp. Ther. 113(1955), 272.

    Google Scholar 

  143. M. C. Kloetzel, S. J. Davis, U. Pandit, C. R. Smithand H. Nishihara, J. mednl pharm. Chem. 1(1959), 197.

    Google Scholar 

  144. A. Sekera, J. Sova, and V. Vrba, Experientia 11(1955), 275.

    Google Scholar 

  145. N. Löfgrenand B. Lundquist, Svensk kem. Tidskr. 58(1946), 206.

    Google Scholar 

  146. K. Bullockand J. Grundy, J. Pharm. Pharmac. 7(1955), 755.

    Google Scholar 

  147. L. Ther, in: Medizin und Chemie, vol. VI, p. 399 ( Farbwerke Hoechst A.G. Verlag Chemie, Weinheim 1958 ).

    Google Scholar 

  148. N. J. Harper, in: Drug Research, vol. 4, p. 221 (Ed., E. Jucker, Birkhäuser Verlag, Basel 1962 ).

    Google Scholar 

  149. J. B. van der Schoot, E. J. Ariens, J. M. van Rossum, and J. A. Th. M. Hurkmans, Arzneimittel-Forsch. 12(1962), 902.

    Google Scholar 

  150. C. C. Pfeiffer, Science 124(1956), 29.

    Google Scholar 

  151. B. W. J. Ellenbroek, Ph.D. Thesis University Nijmegen (1964).

    Google Scholar 

  152. B. W. J. Ellenbroek, R. J. F. Nivard, J. M. van Rossum, and E. J. Ariens, J. Pharm. Pharmac. 17(1965), 393.

    Google Scholar 

  153. E. W. Gill, in: Progress in Medicinal Chemistry, vol. 4, p. 39 (Eds., G. P. Ellisand GB. West, Butterworths, London 1965 ).

    Google Scholar 

  154. J. Hirschfelder: Molecular Biophysics, p. 325 (Eds., B. Pullman and M. Weisbluth, Acad. Press, New York 1965 ).

    Google Scholar 

  155. P. Ehrlich, Ber. 42(1909), 17.

    Google Scholar 

  156. C. Martiusand D. Nitz-Litzow, Biochem. Z. 327(1955), 1.

    Google Scholar 

  157. C. Martius, Dt. med. Wschr. 83(1958), 1701.

    Google Scholar 

  158. K. Hofmann, Brookhaven Symp. Biol. 13(1960), 184.

    Google Scholar 

  159. K. Hofmann, Proceedings International Congress of Pharmaceutical Chemistry, Florence 1962, p. 245 ( Butterworths, London 1963 ).

    Google Scholar 

  160. R. Schwyzer, Proceedings International Congress of Pharmaceutical Chemistry, Florence 1962, p. 265 ( Butterworths, London 1963 ).

    Google Scholar 

  161. G. Cavallini, E. Massarani, D. Nardiand L. Mauri, Gazz. Malatt. infett. 13(1961), 255.

    Google Scholar 

  162. A. Burger, New Engl. J. Med. 270(1964), 1099.

    Google Scholar 

  163. W. C. J. Ross, Biological Alkylating Agents( Butterworths, London 1962 ).

    Google Scholar 

  164. R. D. O’Brien, Toxic Phosphorus Esters, p. 325 ( Acad. Press, New York 1960 ).

    Google Scholar 

  165. R. Riemschneider: Advances in Pest Control Research, vol. II, p. 315 (Ed., R. L. Metcalf, Intersci. Pubi., New York 1958 ).

    Google Scholar 

  166. J. A. Montgomery, in: Progress in Drug Research, vol. 8, p. 438 (Ed., E. Jucker, Birkhäuser Verlag, Basel 1965 ).

    Google Scholar 

  167. F. Bergel, in: Chemotherapy of Cancer, Proc. Int. Symp. Lugano1964, p. 21 ( Ed., P. A. Plattner, Elsevier Pubi. Comp., Amsterdam 1964 ).

    Google Scholar 

  168. J. A. Stock, in: Amino Acids and Peptides with Antimetabolic Activity, Ciba Foundation Symposium, p. 89 ( Churchill, London 1958 ).

    Google Scholar 

  169. N. J. Perevodchikovaand NN. Blokhin, in: Amino Acids and Peptides with Antimetabolic Activity, Ciba Foundation Symposium, p. 110 ( Churchill, London 1958 ).

    Google Scholar 

  170. L. Nemeth, B. Kellnerand K. Lapis, Ann. N.Y. Acad. Sci. 68(1958), 879.

    Google Scholar 

  171. L. F. Larionov, in: Biological Approaches to Cancer Chemotherapy, p. 139 ( Ed., R. J. C. Harris, Acad. Press, New York 1961 ).

    Google Scholar 

  172. L. Vargha, L. Toldy, O. Feher, T. Horvath, E. Kaztreiner, J. Kuszmannand S. Landvoi, Acta physiol. hung. 91(1961), 305.

    Google Scholar 

  173. A. Albert, Pharmac. Rev. 4(1952), 136.

    Google Scholar 

  174. B. Pullman, Electronic Aspects of Biochemistry, p. 559 ( Acad. Press, New York 1964 ).

    Google Scholar 

  175. A. Albert, Selective Toxicity( Methuen, London 1960 ).

    Google Scholar 

  176. K. Sterling, J. clin. Invest. 43(1964), 1721.

    Google Scholar 

  177. H. Bennhold, Klin. Wschr. 41(1963), 111.

    Google Scholar 

  178. H. Arnold, Pharm. Ztg 109(1964), 350.

    Google Scholar 

  179. H. J. Schaeffer, Vince, J. Med. Chem. 8(1965), 33.

    Google Scholar 

  180. K. Hofmann, Brookhaven Symp. Biol. 13(1960), 184.

    Google Scholar 

  181. R. Schwyzer, Proceedings International Congress of Pharmaceutical Chemistry, Florence 1962, p. 265 ( Butterworths, London 1963 ).

    Google Scholar 

  182. K. Hofmann, Proceedings International Congress of Pharmaceutical Chemistry, Florence 1962, p. 245 ( Butterworths, London 1963 ).

    Google Scholar 

  183. F. W. Schueler, Bull. Tulane med. Fac. 24(1964), 7.

    Google Scholar 

  184. H. L. FriedmanNatn Acad. Sci., Natn Res. Coun. Pubi., No. 206(1951), 295.

    Google Scholar 

  185. H. L. Friedman Symposium on Chemical-Biological Correlation, Natn Res. Coun. (Washington, May 1950 ).

    Google Scholar 

  186. V. B. Schatz, in: Medicinal Chemistry, 2nd Edn, p. 72 (Ed., A. Burger, Intersci. Pubi., New York 1960 ).

    Google Scholar 

  187. G. M. Dysonand P. May, May’s Chemistry of Synthetic Drugs, p. 34 ( Longmans, London 1959 ).

    Google Scholar 

  188. A. Burger, Medicinal Chemistry, 2nd Edn, p. 526 ( Intersci. Pubi., New York 1960 ).

    Google Scholar 

  189. P. Ehrlich, Ber. 42(1909), 17.

    Google Scholar 

  190. B. Berde, Pharmacologie des hormones neurohypophysaires et de leurs analogues synthétiques( Masson et Cie., Paris 1963 ).

    Google Scholar 

  191. G. W. Bisset, J. Physiol. 165(1963), 69 - 71 P.

    Google Scholar 

  192. B. Berde, R. A. Boissonnas, R. L. Huguenin, and E. Stürmer, Experientia 20(1964), 42.

    Google Scholar 

  193. G. Sayers and R. H. Travis, in: The Pharmacological Basis of Therapeutics, 3rd Edn, p. 1579 (Eds., L. S. Goodman and A. Gilman, McMillan, New York 1965 ).

    Google Scholar 

  194. R. A. Anderson and E. Hardenbergh, J. surg. Res. 5(1965), 256.

    Google Scholar 

  195. I. Schechter and S. Hestrin, J. Lab. clin. Med. 61(1963), 962.

    Google Scholar 

  196. W. C. Hueper, J. natn Cancer. Inst. 26(1961), 229.

    Google Scholar 

  197. L. Havers, I. von Borgstede, and H. Breuer, Dt. med. Wschr. 87(1962), 730.

    Google Scholar 

  198. Knoefel and Lehmann, J. Pharmac. exp. Ther. 83 (1954).

    Google Scholar 

  199. P. Novack, in: Drill’s Pharmacology in Medicine, 3rd Edn, p. 1437 (Ed., J. R. Di-Palma, Mcgraw-Hill Book Comp., New York 1965 ).

    Google Scholar 

  200. E. Hanssonand CG. Schmiterlöw, Archs int. Pharmacodyn. 131(1961), 309.

    Google Scholar 

  201. R. J. Mcisaacand GB. Koelle, J. Pharmac. exp. Ther. 126(1959), 9.

    Google Scholar 

  202. G. B. Koelle, Handbuch der experimentellen Pharmakologie, vol. XV, p. 187 ( Springer Verlag, Berlin 1963 ).

    Google Scholar 

  203. G. B. Koelle,in: Bioelectrogenesis, p. 314 ( Eds., C. Chagas and A. Paes de Carvalho, Elsevier Publ. Comp., Amsterdam 1961 ).

    Google Scholar 

  204. Z. Votava, J. Metys, and J. Metysovà-Srâmkovâ, in: Pharmacotherapeutica 1950–1959, p. 307. Collection of papers 10th anniv. Research Institute of Pharmacy and Biochemistry, Prague (Ed., O. Hanc, Prague 1960 ).

    Google Scholar 

  205. R. D. O’Brien Toxic Phosphorus Esters, p. 289 and p. 355 ( Acad. Press, New York 1960 ).

    Google Scholar 

  206. H. Martin, in: Selective Toxicity and Antibiotics, 3rd Symposia of Society for Exp. Biol., p. 105 ( Cambridge University Press, Cambridge 1949 ).

    Google Scholar 

  207. W. E. Ripper, in: Advances in Pest Control Research, vol. I, p. 305 (Ed., R. L. Metcalf, Intersci. Publ., New York 1957 ).

    Google Scholar 

  208. H. T. Reynolds, in: Advances in Pest Control Research, vol. II, p. 135 (Ed., R. L. Metcalf, Intersci. Publ., New York 1958 ).

    Google Scholar 

  209. S. H. Bennett, A. Rev. Ent. 2, (1957) 279.

    Google Scholar 

  210. R. L. Metcalf, Plant Protection Conference 1956, Proc. 2nd Int. Fernhurst Res. Sta., England, p. 129 (1957).

    Google Scholar 

  211. J. F. Reith, in: Kleur van levensmiddelen, p. 15 ( D. B. Centen’s Uitg. Mij., Hilversum, Netherlands 1960 ).

    Google Scholar 

  212. T. S. Scott, Carcinogenic and Chronic Toxic Hazards of Aromatic Amines, Elsevier Monographs on Toxic Agents (Elsevier Publ. Comp., Amsterdam 1962 ).

    Google Scholar 

  213. Food and Agriculture Organization of the U.S., Specifications for Identity and Purity of Food Additives, vol. II ( Food Colors, F.A.O. Rome 1963 ).

    Google Scholar 

  214. A. Hamilton and H. L. Hardy, Industrial Toxicology, 2nd Edn (P. B. Hoeber Inc., New York 1949 ).

    Google Scholar 

  215. F. A. Patty, Industrial Hygiene and Toxicology, vol. II, 2nd Edn (Intersci. Publ., New York 1962 ).

    Google Scholar 

  216. R. Fabre, Actual, pharmac. 10(1957), 117.

    Google Scholar 

  217. N. A. Lassen, Lancet II(1960), 338.

    Google Scholar 

  218. A. Myschetzkyand NA. Lassen, Danish Med. Bull. 10(1963), 97.

    Google Scholar 

  219. A. H. Beckettand M. Rowland, J. Pharm. Pharmac. 17(1965), 628.

    Google Scholar 

  220. A. S. Crafts, Science 108(1948), 85.

    Google Scholar 

  221. A. S. Crafts, in: Advances in Pest Control Research, vol. I, p. 72 (Ed., R. L. Metcalf, Intersci. Publ., New York 1957 ).

    Google Scholar 

  222. S. Archer, J. O. Hoppe, T. R. Lewis, and M. N. Haskell, J. Am. pharm. Ass. (Sci. Edn) 40(1951), 143.

    Google Scholar 

  223. A. H. Soloway, Prog. Boron Chem. 1(1964), 203.

    Google Scholar 

  224. A. H. Soloway, B. Whitmanand JR. Messer, J. Pharmac. exp. Ther. 129(1960), 310.

    Google Scholar 

  225. A. H. Soloway, J. mednl pharm. Chem. 5(1962), 1371.

    Google Scholar 

  226. Ch. A. Winter and C. C. Porter, J. Am. pharm. Ass. (Sci. Edn) 46(1957), 515.

    Google Scholar 

  227. W. Dirscherland HL. Krüskemper, Biochem. Z. 323(1953), 520.

    Google Scholar 

  228. L. Weinstein, in: The Pharmacological Basis of Therapeutics, 3rd Edn, p. 1144 (Eds., L. S. Goodman and A. Gilman, McMillan Comp., New York 1965 ).

    Google Scholar 

  229. T. Matsukawa, S. Yurugiand Y. Oka, Ann. N.Y. Acad. Sci. 98(1962), 31.

    Google Scholar 

  230. E. F. Rogers, Ann. N.Y. Acad. Sci. 98(1962), 412.

    Google Scholar 

  231. C. Kawasaki: Vitamins and Hormones, vol. 21, p. 69 (Eds., R. S. Harris, I. G. Wooland JA. Loraine, Acad. Press, New York 1963 ).

    Google Scholar 

  232. Y. Cohen, A. Uzanand G. Valette, Biochem. Pharmac. 11(1962), 721.

    Google Scholar 

  233. Kunio Yagi, Jun Okuda, A. A. Dmitrovskii, Rikuko Honda, and Toshiro Matsubara, J. Vitam. 7(1961), 4.

    Google Scholar 

  234. Editorial Japan Medical Gazette 211(1965), 15.

    Google Scholar 

  235. Y. Imai, Personal Communication, Takeda Chem. Ind., Osaka.

    Google Scholar 

  236. Y. Imai, Chem. pharmac. Bull., Tokyo, Pharmac. Soc. Japan (in press).

    Google Scholar 

  237. H. Imura, S. Matsukura, H. Matsuyama, T. Sitsuda, and T. Miyaka, Endocrinol. 70(1965), 933.

    Google Scholar 

  238. A. D. Welch, Cancer Res. 21(1961), 1475.

    Google Scholar 

  239. A. S. Crafts, in: Advances in Pest Control Research, vol. I, p. 50 (Ed., R. L. Metcalf, Intersci. Publ., New York 1957 ).

    Google Scholar 

  240. F. BergelJ. Pharm. Pharmac. 7(1955), 297.

    Google Scholar 

  241. W. C. J. Ross, Acta Un. int. Cancr. 10(2) (1954), 159.

    Google Scholar 

  242. J. L. Garrawayand RL. Wain, Ann. appl. Biol. 50(1962), 11.

    Google Scholar 

  243. M. E. Synerholmand PW. Zimmerman, Contr. Boyce Thompson Inst. PI. Res. 14(1947), 369.

    Google Scholar 

  244. H. R. Ing, in: Fortschritte der Arzneimittelforschung, vol. 7, p. 306 (Ed., E. Jucker, Birkhäuser Verlag, Basel 1964 ).

    Google Scholar 

  245. C. G. Raisonand OD. Standen, Br. J. Pharmac. 10(1955), 191.

    Google Scholar 

  246. A. G. Caldwelland OD. Standen, Br. J. Pharmac. 11(1956), 372.

    Google Scholar 

  247. P. Karrer, Lehrbuch der organischen Chemie, p. 216 ( George Thieme Verlag, Stuttgart 1959 ).

    Google Scholar 

  248. P. K. Knoefelin: Drill’s Pharmacology of Medicine, 3rd Edn, p. 1429 (Ed., J. R. Dipalma, Mcgraw-Hill Book Comp., New York 1965 ).

    Google Scholar 

  249. P. K. Knoefel Radiopaque Diagnostic Agents(Charles C. Thomas, Springfield, Illinois, 1961 ).

    Google Scholar 

  250. O. v. St. Whitelock, Radiopaque Diagnostic Agents, Ann. N.Y. Acad. Sci. 78 (1959), 705.

    Google Scholar 

  251. A. Farah, M. Frazerand E. Porter, J. Pharmac. exp. Ther. 126(1959), 202.

    Google Scholar 

  252. R. E. Green, W. E. Ricker, W. L. Attwood, Y. S. Kohand L. Peters, J. Pharmac. exp. Ther. 126(1959), 195.

    Google Scholar 

  253. R. L. Volle, L. Petersand RE. Green, J. Pharmac. exp. Ther. 129(1960), 377.

    Google Scholar 

  254. J. S. Mitchell, Proc. R. Soc. Med. 56, (1963) 651.

    Google Scholar 

  255. W. Davis, Current Trends in the Design of Anti-Tumor Agents, 12e Jaarboek Kankeronderzoek en Kankerbestrijding in Nederland, p. 113 (1962).

    Google Scholar 

  256. F. BergelJ. M. Johnson, and R. Wade, J. chem. Soc. 1962, 3802.

    Google Scholar 

  257. L. F. Larionovand GN. Platonova, Vop. Onkol. 1(1955), 36.

    Google Scholar 

  258. L. A. Ignatovaand MI. Goriaev, Akad. Nauk Kazakh. 6(1960), 207.

    Google Scholar 

  259. L. F. Larionov, Vest. Akad. Med. Nauk 4(1960), 29.

    Google Scholar 

  260. E. N. Shkodinskaya, O. S. Vasina, A. Ya. Berlin, Z. P. Sofinaand LF. Larionov, Zh. obshch. Khim. 32(1962), 324.

    Google Scholar 

  261. L. F. Larionov, Cancer Chemother. Rep. 12(1961), 205.

    Google Scholar 

  262. D. A. Lyttleand HG. Petering, J. Am. chem. Soc. 80(1958), 6459.

    Google Scholar 

  263. J. A. Stock, in: Amino Acids and Peptides with Antimetabolic Activity, p. 89 ( Ciba Foundation Symposium, Churchill, London 1958 ).

    Google Scholar 

  264. L. F. Larionov, Br. J. Cancer 10(1956), 26.

    Google Scholar 

  265. P. C. Kollerand U. Veronesi, Br. J. Cancer 10(1956), 703.

    Google Scholar 

  266. L. F. Larionovand Z. P. Sofina, C. r. Acad. Sci. U.R.S.S. 114(1957), 1070.

    Google Scholar 

  267. J. M. Luck, Cancer Res. 17(1957), 1071.

    Google Scholar 

  268. S. S. Brown, in: Advances in Pharmacology, vol. 2, p. 243 (Eds., S. Garattini and PA. Shore, ), Acad. Press, New York 1963 ).

    Google Scholar 

  269. L. F. Larionov, in: Cancer Progress, p. 211 ( Butterworth, London 1960 ).

    Google Scholar 

  270. Z. P. Sofina, Trudy 2nd Vsesoiuz Konf. Onkol. Lenin, p. 773 ( Medgiz, Leningrad 1959 ).

    Google Scholar 

  271. H. Ch. Reilly, in: Amino Acids and Peptides with Antimetabolic Activity, p. 62 ( Ciba Foundation Symposium, Churchill, London 1958 ).

    Google Scholar 

  272. L. Vargha,L. Toldy, O. Feherand S. Lendvai, J. chem. Soc. 1957, 805.

    Google Scholar 

  273. L. Vargha,Ann. N.Y. Acad. Sci. 68(1958), 875.

    Google Scholar 

  274. R. Jones, U. Jonsson, M. Browning, H. Lessner, C. C. Priceand AK. Sen, Ann. N.Y. Acad. Sci. 68(1958), 1133.

    Google Scholar 

  275. H. J. Creech, Ann. N.Y. Acad. Sci. 68(1958), 868.

    Google Scholar 

  276. J. F. Danielli, A. Rep. Br. Emp. Cancer Campn 34(1956), p. 398.

    Google Scholar 

  277. J. F. Danielli, A. Rep. Br. Emp. Cancer Campn 38(1960), p. 693.

    Google Scholar 

  278. H. Druckrey, Klin. Wschr. 30(1952), 882.

    Google Scholar 

  279. W. C. J. Ross, Biochem. Pharmac. 13(1964), 969.

    Google Scholar 

  280. N. Brock, Proceedings 2nd International Symposium of Chemotherapy, Naples 1961, part III, p. 1 (Eds., H. P. Kuemmerle, P. Preziosi and P. Rentchnick, Karger, Basel 1963 ).

    Google Scholar 

  281. H. Grunicke, M. Liersch, H. Holzerund H. Arnold, Biochem. Pharmac. 14(1965), 1495.

    Google Scholar 

  282. J. F. Danielli, A. Rep. Br. Emp. Cancer Campn 37(1959), 575.

    Google Scholar 

  283. J. F. Danielli, in: Biological Approaches to Cancer Chemotherapy, p. 2 ( Ed., R. J. C. Harris, Acad. Press, New York 1961 ).

    Google Scholar 

  284. E. O. Westermann, Proceedings 1st International Pharmacological Meeting, Stockholm 1961, vol. 6, p. 15 ( Pergamon Press, Oxford 1963 ).

    Google Scholar 

  285. P. Holtzand E. Westermann, Arch. exp. Path. Pharmak. 239(1960), 1.

    Google Scholar 

  286. D. F. Heath, P. O. Park, L. A. Lickerishand EF. Edson, Pest Control Ltd. (Mimeo Report 1953 ).

    Google Scholar 

  287. W. E. Ripper, in: Advances in Pest Control Research, vol. I, p. 307 (Ed., R. L. Metcalf, Intersci. Pubi., New York 1957 ).

    Google Scholar 

  288. H. R. Krueger, and R. D. O’BrienJ. econ. Ent. 52(1959), 1063.

    Google Scholar 

  289. J. P. Frawley, H. N. Fuyat, E. C. Hagan, J. R. Blakeand O. Garth Fitzhugh, J. Pharmac. exp. Ther. 121(1957), 96.

    Google Scholar 

  290. R. D. O’BrienAnn. N.Y. Acad. Sci. 123(1965), 156.

    Google Scholar 

  291. H. D. Esserand PW. Muller, Experientia 22(1966), 38.

    Google Scholar 

  292. R. Carson, Silent Spring ( Houghton, Boston 1962 ).

    Google Scholar 

  293. P. A. Dahm, in: Advances in Pest Control Research, vol. I, p. 86 (Ed., R. L. Metcalf, Intersci. Pubi. Inc., New York 1957 ).

    Google Scholar 

  294. K. Junkmannand H. Witzel, Z. Vitam.-Horm.- u. Fermentforsch. 9(1958), 227.

    Google Scholar 

  295. E. B. Astwood, in: The Pharmacological Basis of Therapeutics, 3rd Edn, p. 1540 (Eds., L. S. Goodman and A. Gilman, McMillan Comp., New York 1965 ).

    Google Scholar 

  296. R. H. Travisand G. Sayers, in: The Pharmacological Basis of Therapeutics, 3rd Edn, p. 1608 (Eds., L. S. Goodman and A. Gilman, McMillan Comp., New York 1965 ).

    Google Scholar 

  297. G. Dörnerand E. Kleinert, Acta biol. med. germ. 11(1963), 77.

    Google Scholar 

  298. J. van der Vies, Acta endocr. 49(1965), 271.

    Google Scholar 

  299. J. Kuntzeand FI. Otto, Dt. med. Wschr. 76(1951), 472.

    Google Scholar 

  300. J. R. Dipalma, Drill’s Pharmacology in Medicine, 3rd Edn ( Mcgraw-Hill Book Comp., New York 1965 ).

    Google Scholar 

  301. R. E. Thompsonand RA. Hecht, Am. J. clin. Nutr. 7(1959), 311.

    Google Scholar 

  302. T. A. Garrett, Clin. Med. 3(1956), 1185.

    Google Scholar 

  303. K. O. Moller, Pharmakologie als theoretische Grundlage einer rationellen Pharmakotherapie, p. 203 ( Benno Schwabe and Co. Verlag, Basel 1958 ).

    Google Scholar 

  304. E. Dicfalusy, O. Fernö, H. Fexand B. Högberg, Acta chem. scand. 17(1963), 2536.

    Google Scholar 

  305. G. A. Overbeek, J. van der Viesand J. de Visser, Proceedings International Symposium on Protein Metabolism, p. 185 (Ed., F. Gross, Springer Verlag, Berlin 1962 ).

    Google Scholar 

  306. G. A. Overbeek, Symposium on Anabolic Therapy, Michigan and Wayne County Acad. Gen. Practice, March 21, 1962 (Detroit 1962 ).

    Google Scholar 

  307. R. M. Levineand BB. Clark, J. Pharmac. exp. Ther. 113(1955), 272.

    Google Scholar 

  308. A. H. Beckett, NJ. Harper, and J. W. Clitherow, Unpublished work.

    Google Scholar 

  309. M. C. Kloetzel, S. J. Davis, U. Pandit, C. R. Smith and H. Nishihara, J. mednl pharm. Chem. 1(1959), 197.

    Google Scholar 

  310. D. Glick, J. biol. Chem. 125(1938), 729; 130(1939), 527; 137(1941), 357.

    Google Scholar 

  311. S. J. Fu, S. M. Birnbaumand JP. Greenstein, J. Am. chem. Soc. 76(1954), 6054.

    Google Scholar 

  312. A. Sekera, J. Sovaand V. Vrba, Experientia 11(1955), 275.

    Google Scholar 

  313. N. Löfgrenand B. Lundquist, Svensk kem. Tidskr. 58(1946), 206.

    Google Scholar 

  314. V. Hach, Cslka Farm. 2(1953), 159.

    Google Scholar 

  315. H. Grasshof, in: Progress in Drug Research, vol. 4, p. 354 (Ed., E. Jucker, Birkhäuser Verlag, Basel 1962 ).

    Google Scholar 

  316. K. Bullockand J. Grundy, J. Pharm. Pharmac. 7(1955), 755.

    Google Scholar 

  317. A. Sekera, J. Sovaand C. Vrba, Experientia 11, (1955) 275.

    Google Scholar 

  318. L. Tker, in: Medizin und Chemie, vol. VI, p. 399 ( Farbwerke Hoechst A.G., Verlag Chemie, Weinheim 1958 ).

    Google Scholar 

  319. J. B. van der Schoot,E. J. Ariens, J. M. van Rossum, and J. A. Th. M. Hurkmans, Arzneimittel-Forsch. 12(1962), 902.

    Google Scholar 

  320. J. B. van der Schoot, Central Stimulating Phenylethylamines, Ph. D. Thesis University Nijmegen (Nijmegen 1961 ).

    Google Scholar 

  321. L. E. Leafe, Nature 193(1962), 485.

    Google Scholar 

  322. A. S. Crafts, in: Advances in Pest Control Research, vol. I, p. 43 (Ed., R. L. Metealf, Intersci. Publ., New York 1957 ).

    Google Scholar 

  323. A. H. Conney, M. Sansur, F. Soroko, R. Koster, and J. J. Burns, J. Pharmac. exp. Ther. 151(1966), 133.

    Google Scholar 

  324. J. J. Burns and R. A. Salvador, Conference on New Adrenergic Blocking Drugs, February 24–26 1966, N.Y. Acad. Sci. ( New York 1966 ).

    Google Scholar 

  325. H. W. Gerarde, Toxicology and Biochemistry of Aromatic Hydrocarbons, Elsevier Monographs on Toxic Agents (Elsevier Publ. Comp., Amsterdam 1960 ).

    Google Scholar 

  326. D. D. Dziewiatkowskiand HB. Lewis, J. biol. Chem. 158, (1945) 77.

    Google Scholar 

  327. I. A. Kamil, J. N. Smithand RT. Williams, Biochem. J. 53(1953), 137.

    Google Scholar 

  328. H. D. Law, in: Progress in Medicinal Chemistry, vol. 4, p. 86 (Eds., G. P. Ellisand G. B. West, Butterworths, London 1965 ).

    Google Scholar 

  329. H. Brunnerand D. Regoli, Experientia 18(1962), 504.

    Google Scholar 

  330. R. Schwyzer, Proceedings International Congress of Pharmaceutical Chemistry, Florence 1962, p. 265 ( Butterworth, London 1963 ).

    Google Scholar 

  331. I. Rychlik, Proceedings 2nd International Pharmacological Meeting, August 20–23, Prague 1963, vol. 10, p. 153 ( Pergamon Press, Oxford 1964 ).

    Google Scholar 

  332. J. Rüdingerand K. Jost, Proceedings 2nd International Pharmacological Meeting, August 20–23, Prague 1963, vol. 10, p. 3 ( Pergamon Press, Oxford 1964 ).

    Google Scholar 

  333. Z. Beränkovä-Ksandrova, I. Rychlikand F. Sorm, Proceedings 2nd International Pharmacological Meeting, August 20–23, Prague 1963, vol. 10, p. 181 ( Pergamon Press, Oxford 1964 ).

    Google Scholar 

  334. M. Zaoraland F. Sorm, Proceedings 2nd International Pharmacological Meeting, August 20–23, Prague 1963, vol. 10, p. 167 ( Pergamon Press, Oxford 1964 ).

    Google Scholar 

  335. M. Zaoral, V. Pliska, K. Rezäbekand F. Sorm, Colin Czech, chem. Commun. 28(1963), 747.

    Google Scholar 

  336. J. Büchi, P. Labhartand L. Ragaz, Helv. Chim. Acta 30(1947), 507.

    Google Scholar 

  337. H. Vanderhaeghe, P. Kolosyand M. Claesen, J. Pharm. Pharmac. 6(1954), 119; 7 (1955), 477.

    Google Scholar 

  338. M. Häringand G. Stille, Helv. Chim. Acta 44(1961), 642.

    Google Scholar 

  339. A. Sekera, Actual, pharmac. 14(1961), 212.

    Google Scholar 

  340. F. M. Berger, Proc. Soc. exp. Biol. Med. 71(1949), 270.

    Google Scholar 

  341. F. M. Berger, J. Pharmac. exp. Ther. 104(1952), 229.

    Google Scholar 

  342. F. G. Mcmahon, in: Molecular Modification in Drug Design, p. 102, Adv. Chem. Ser. 45 (Ed., R. F. Gould, American Chemical Society, Washington 1964 ).

    Google Scholar 

  343. F. L. M. Pattison, Toxic Aliphatic Fluorine Compounds( Elsevier, Amsterdam 1959 ).

    Google Scholar 

  344. R. A. Peters, Discuss. Faraday Soc. 20(1955), 189.

    Google Scholar 

  345. R. A. Peters, Bull. Johns Hopkins Hosp. 97(1955), 21.

    Google Scholar 

  346. R. Duschinsky, E. Plevenand C. Heidelberger, J. Am. chem. Soc. 79(1957), 4559.

    Google Scholar 

  347. L. Bosch, E. Harbersand C. Heidelberger, Cancer Res. 18(1958), 335.

    Google Scholar 

  348. S. S. Cohen, J. G. Flaks, H. D. Barner, M. R. Loeband J. Lichtenstein, Proc. natn. Acad. Sci. U.S. 44(1958), 1004.

    Google Scholar 

  349. A. H. Anton, J. Pharmac. exp. Ther. 129(1960), 282.

    Google Scholar 

  350. H. Berlinand E. Krüger-Thiemer, Transln Nord. Med. 72(1964), 1358.

    Google Scholar 

  351. W. Scholtan, Arzneimittel-Forsch. 11(1961), 707.

    Google Scholar 

  352. W. Scholtan, Arzneimittel-Forsch. 14(1964), 348, 469, 1139, 1234.

    Google Scholar 

  353. E. Brandl, R. Brunnerand F. Knauseder, Arzneimittel-Forsch. 14(1964), 883.

    Google Scholar 

  354. A. Goldstein, Pharmac. Rev. 1(1949), 102.

    Google Scholar 

  355. A. H. Anton, Fed. Proc. 20(1961), 171.

    Google Scholar 

  356. U. Westphal, in: Mechanism of Action of Steroid Hormones, p. 33 (Ed., C. A. Villee, Pergamon Press, New York 1961 ).

    Google Scholar 

  357. A. H. Anton, J. Pharmac. exp. Ther. 134(1961), 291.

    Google Scholar 

  358. C. M. Kunin, J. Lab. clin. Med. 65(1965), 406, 416.

    Google Scholar 

  359. C. M. Kunin, Clin. Pharmac. Ther. 7(1966), 166, 180.

    Google Scholar 

  360. P. de Moor, R. Deckx, and O. Steeno, J. Endocr. 27(1963), 355.

    Google Scholar 

  361. A. Vermeulen, Thesis University of Ghent, Belgium (1960).

    Google Scholar 

  362. J. M. van Rossum,E. J. Ariens, and G. H. Linssen, Biochem. Pharmac. 7(1958), 193.

    Google Scholar 

  363. H. R. Griffith, W. C. Cullen, and P. Welt, Can. Anaesth. Soc. J. 3(1956), 346.

    Google Scholar 

  364. D. Haunfelderand G. Kodel, Das Deutsche Zahnärzteblatt 15(1961), 339.

    Google Scholar 

  365. K. Horatz, R. Freyand M. Zindler, Bericht über die Arbeitstagung der Deutschen Gesellschaft für Anästhesie, 25. Januar 1964, Frankfurt a. Main. Die intravenöse Kurznarkose mit dem neuen Phenoxyessigsäurederivat Propanidid (Epontol) ( Springer Verlag, Berlin 1965 ).

    Google Scholar 

  366. J. Putter, in: Bericht über die Arbeitstagung der Deutschen Gesellschaft für Anästhesie, 25. Januar 1964, Frankfurt a. Main, p. 61 (Eds. K. Horatz, R. Frey, and M. Zindler, Springer Verlag, Berlin 1965 ).

    Google Scholar 

  367. B. Witten, C. E. Williamson, S. Sass, J. I. Miller, R. Best, G. E. Wicks, jr., S. P. Kramer, T. Weinberg, R. D. Solomon, L. E. Goodmanand AM. Seligman, Cancer 15(1962), 1041.

    Google Scholar 

  368. B. Witten, C. E. Williamson, S. Sass, J. I. Miller, R. Best, G. E. Wicks, jr., S. P. Kramer, T. Weinberg, R. D. Solomon, L. E. Goodmanand AM. Seligman, Cancer 15(1962), 1062.

    Google Scholar 

  369. L. Ther, in: Medizin und Chemie, vol. VI, p. 399 ( Farbwerke Hoechst A.G., Verlag Chemie, Weinheim 1958 ).

    Google Scholar 

  370. H. S. Mathewson, Structural Forms of Anesthetic Compounds, p. 86 (C. C. Thomas, Springfield 111. 1961 ).

    Google Scholar 

  371. S. K. Sharpless, in: The Pharmacological Basis of Therapeutics, 3rd Edn, p. 105 (Eds., L. S. Goodmanand A. Gilman, McMillan Comp., New York 1965 ).

    Google Scholar 

  372. M. T. Busch, in: Physiological Pharmacology, vol. I, p. 185 (Eds., W. S. Root and F. G. Hofmann, Acad. Press, New York 1963 ).

    Google Scholar 

  373. E. W. Maynert, in: Drill’s Pharmacology in Medicine, 3rd Edn, p. 188 (Ed., J. R. Dipalma, Mcgraw-Hill Book Comp., New York 1965 ).

    Google Scholar 

  374. E. E. Swanson, W. R. Gibson, and W. J. Doran, J. Am. pharm. Ass. (Sci. Edn) 44(1955), 152.

    Google Scholar 

  375. B. B. Brodie, Fed. Proc. Am. Soc. exp. Biol. 11(1952), 632.

    Google Scholar 

  376. R. Hiltmann, H. Wollweber, W. Wirthand F. Hoffmeister, in: Bericht über die Arbeitstagung der Deutschen Gesellschaft für Anästhesie, 25. Januar 1964, Frankfurt a. Main, p. 1 (Eds., K. Horatz, R. Frey, and M. Zindler, Springer Verlag, Berlin 1965 ).

    Google Scholar 

  377. M. J. Thuillierand R. Domenjoz, Anaesthetist 6(1957), 163.

    Google Scholar 

  378. J. C. Brinling, T. D. Shopiroand E. B. Sigg, Archs int. Pharmacodyn. Ther. 136(1962), 113.

    Google Scholar 

  379. W. Wirthand F. Hoffmeister, in: Bericht über die Arbeitstagung der Deutschen Gesellschaft für Anästhesie, 25. Januar 1964, Frankfurt a. Main, p. 17 (Eds., K. Horatz, R. Frey, and M. Zindler, Springer Verlag, Berlin 1965 ).

    Google Scholar 

  380. D. Boyle, A. W. Dellipiani, J. A. Owen, D. A. Seatonand R W. Tonkin, Br. med. J. 1(1964), 285.

    Google Scholar 

  381. A. I. Kertesz, The Pectic Substances, p. 393 ( Intersci. Publ., New York 1951 ).

    Google Scholar 

  382. A. Halpern, N. Shafteland AJ. Monte Bovi, Am. J. Pharm. 130(1958), 190.

    Google Scholar 

  383. T. F. Davey, Proceedings of International Congress on Leprosy, Tokyo (November 1958).

    Google Scholar 

  384. N. Valery, Discovery 25(1964), 26.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institute of Pharmacology, University of Nijmegen, The Netherlands

    E. J. Ariëns

Authors
  1. E. J. Ariëns
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Pharmazeutisch-chemische Forschungslaboratorien, Sandoz AG, Basel, Switzerland

    Ernst Jucker

Rights and permissions

Reprints and permissions

Copyright information

© 1966 Birkhäuser Verlag Basel

About this chapter

Cite this chapter

Ariëns, E.J. (1966). Molecular Pharmacology, a Basis for Drug Design. In: Jucker, E. (eds) Fortschritte der Arzneimittelforschung / Progress in Drug Research / Progrès des recherches pharmaceutiques. Fortschritte der Arzneimittelforschung / Progress in Drug Research / Progrès des recherches pharmaceutiques, vol 10. Birkhäuser Basel. https://doi.org/10.1007/978-3-0348-7059-7_8

Download citation

  • DOI: https://doi.org/10.1007/978-3-0348-7059-7_8

  • Publisher Name: Birkhäuser Basel

  • Print ISBN: 978-3-0348-7061-0

  • Online ISBN: 978-3-0348-7059-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation